APA (7th ed.) Citation

O'Malley, D. M., Bariani, G. M., Cassier, P. A., Marabelle, A., Hansen, A. R., De Jesus Acosta, A., . . . Maio, M. (2022). Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study. Journal of clinical oncology, 40(7), 752. https://doi.org/10.1200/JCO.21.01874

Chicago Style (17th ed.) Citation

O'Malley, David M., et al. "Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study." Journal of Clinical Oncology 40, no. 7 (2022): 752. https://doi.org/10.1200/JCO.21.01874.

MLA (9th ed.) Citation

O'Malley, David M., et al. "Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study." Journal of Clinical Oncology, vol. 40, no. 7, 2022, p. 752, https://doi.org/10.1200/JCO.21.01874.